| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 245.37B | 272.74B | 288.98B | 279.35B | 270.02B |
| Gross Profit | 126.31B | 135.40B | 145.65B | 151.69B | 152.84B |
| EBITDA | 56.08B | 57.93B | 56.07B | 61.93B | 58.39B |
| Net Income | 38.83B | 41.70B | 40.79B | 44.81B | 43.41B |
Balance Sheet | |||||
| Total Assets | 7.17T | 6.96T | 6.77T | 6.30T | 5.90T |
| Cash, Cash Equivalents and Short-Term Investments | 1.09T | 517.56B | 538.28B | 525.66B | 574.23B |
| Total Debt | 1.55T | 293.05B | 1.30T | 1.07T | 953.89B |
| Total Liabilities | 6.56T | 6.37T | 6.22T | 5.79T | 5.42T |
| Stockholders Equity | 604.80B | 587.70B | 552.39B | 507.88B | 482.49B |
Cash Flow | |||||
| Free Cash Flow | 155.40B | -214.20B | -8.77B | -61.06B | -117.59B |
| Operating Cash Flow | 162.91B | -204.80B | -3.61B | -56.40B | -112.24B |
| Investing Cash Flow | -103.90B | 123.68B | -205.82B | -103.09B | -93.41B |
| Financing Cash Flow | 52.73B | 85.00B | 196.02B | 70.57B | 286.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.15T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
71 Outperform | HK$456.53B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$501.60B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
57 Neutral | HK$206.60B | 5.64 | 6.61% | 5.53% | -8.41% | -5.52% | |
57 Neutral | HK$651.88B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% | |
52 Neutral | HK$180.84B | 5.60 | 4.68% | 9.09% | -7.28% | -5.00% |